Macroamylasemia: Difference between revisions
(Removing all content from page) |
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
| (8 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{Infobox_Disease | | |||
Name = {{PAGENAME}} | | |||
Image = | | |||
Caption = | | |||
DiseasesDB = | | |||
ICD10 = | | |||
ICD9 = | | |||
ICDO = | | |||
OMIM = | | |||
MedlinePlus = | | |||
eMedicineSubj = | | |||
eMedicineTopic = | | |||
MeshID = | | |||
}} | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Macroamylasemia''' is a benign acquired condition, characterized by a serum [[amylase]] unusually large in molecular size that has been found to occur in apparently healthy humans as well as in a variety of diseases including [[liver disease]], [[diabetes]], [[cancer]], [[malabsorption]] and [[autoimmune disorders]]. Most commonly macroamylasemia results from the formation of immune complexes between [[amylase]] and [[immunoglobulin]]s. | |||
==Differential diagnosis of causes of macroamylasemia== | |||
Macroamylasemia has been associated with: | |||
* [[Autoimmune disorders]] | |||
* [[Cancer]] | |||
* [[Celiac disease]] | |||
* [[Diabetes]] | |||
* [[HIV infection]] | |||
* [[Liver disease]] | |||
* [[Lymphoma]] | |||
* [[Malabsorption]] | |||
* [[Monoclonal gammopathy]] | |||
* [[Rheumatoid arthritis]] | |||
* [[Ulcerative colitis]] | |||
{{Symptoms and signs}} | |||
[[Category:Blood tests]] | |||
[[Category:Gastroenterology]] | |||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
Latest revision as of 17:07, 9 August 2012
| Macroamylasemia |
|
WikiDoc Resources for Macroamylasemia |
|
Articles |
|---|
|
Most recent articles on Macroamylasemia Most cited articles on Macroamylasemia |
|
Media |
|
Powerpoint slides on Macroamylasemia |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Macroamylasemia at Clinical Trials.gov Trial results on Macroamylasemia Clinical Trials on Macroamylasemia at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Macroamylasemia NICE Guidance on Macroamylasemia
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Macroamylasemia Discussion groups on Macroamylasemia Patient Handouts on Macroamylasemia Directions to Hospitals Treating Macroamylasemia Risk calculators and risk factors for Macroamylasemia
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Macroamylasemia |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Macroamylasemia is a benign acquired condition, characterized by a serum amylase unusually large in molecular size that has been found to occur in apparently healthy humans as well as in a variety of diseases including liver disease, diabetes, cancer, malabsorption and autoimmune disorders. Most commonly macroamylasemia results from the formation of immune complexes between amylase and immunoglobulins.
Differential diagnosis of causes of macroamylasemia
Macroamylasemia has been associated with:
- Autoimmune disorders
- Cancer
- Celiac disease
- Diabetes
- HIV infection
- Liver disease
- Lymphoma
- Malabsorption
- Monoclonal gammopathy
- Rheumatoid arthritis
- Ulcerative colitis
Template:Skin and subcutaneous tissue symptoms and signs Template:Nervous and musculoskeletal system symptoms and signs Template:Urinary system symptoms and signs Template:Cognition, perception, emotional state and behaviour symptoms and signs Template:Speech and voice symptoms and signs Template:General symptoms and signs